TFX
Teleflex Inc
$135.73
+1.69 (+1.26%)
At close · Jul 10
Market Cap
$6.01B
Shares
44,270,211
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.99B
-34.6%
FY2025
Net Income
-$905.64M
-1399.8%
FY2025
Gross Margin
56.24%
+0.4pp
FY2025
Operating Margin
5.94%
+1pp
FY2025
Diluted EPS
-$20.25
-1468.2%
FY2025
Operating Cash Flow
$96.68M
-84.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $2.81B | $1.99B | $3.05B | $2.97B | $2.79B | $2.81B | $2.54B | $2.6B | $2.45B | $2.15B | $1.87B | $1.81B | $1.84B | $1.7B | $1.55B | $1.53B | $1.56B | |
| — | $953.97M | $871.96M | $1.34B | $1.33B | $1.26B | $1.26B | $1.21B | $1.1B | $1.06B | $974.5M | $871.83M | $865.29M | $897.4M | $857.33M | $802.78M | $810.07M | $828.9M | |
| — | $1.5B | $1.12B | $1.7B | $1.65B | $1.53B | $1.55B | $1.32B | $1.49B | $1.38B | $1.17B | $996.2M | $944.4M | $942.43M | $838.95M | $748.23M | $718.84M | $732.42M | |
| — | — | 56.24% | 55.87% | 55.37% | 54.86% | 55.15% | 52.22% | 57.47% | 56.55% | 54.6% | 53.33% | 52.19% | 51.22% | 49.46% | 48.24% | 47.02% | 46.91% | |
| — | $163.87M | $144.78M | $161.67M | $154.35M | $153.82M | $130.84M | $119.75M | $113.86M | $106.21M | $84.77M | $58.58M | $52.12M | $61.04M | $65.05M | $56.28M | $48.73M | $42.62M | |
| — | $793.27M | $720.17M | $995.27M | $929.87M | $863.75M | $860.09M | $743.57M | $934.37M | $878.69M | $699.96M | $563.31M | $568.98M | $578.66M | $502.19M | $454.49M | $429.26M | $431.1M | |
| — | — | $121.66M | $197.67M | $173.97M | $164.09M | $165.6M | $158.69M | $149.97M | $149.49M | $98.77M | $63.49M | $62.38M | $60.93M | $50.61M | $44.26M | $44.11M | $43.06M | |
| — | $192.86M | $177.74M | $274.6M | $242.12M | $230.59M | $237.36M | $227.25M | $218.37M | $214.71M | $160.34M | $128.35M | $125.33M | $127.03M | — | $94.88M | — | — | |
| — | $39.91M | $24.49M | $14.16M | $18.8M | $18.8M | $15M | $17.1M | $15.24M | $60.12M | $14.79M | $15.87M | $7.82M | $27.61M | — | — | $461K | — | |
| — | — | — | — | — | — | — | — | — | — | — | $2.4M | — | — | — | — | — | — | |
| — | -$219.53M | $118.37M | $151.01M | $506.31M | $499.73M | $628.1M | $423.07M | $427.25M | $321.7M | $372.28M | $319.45M | $315.89M | $284.86M | $233.26M | -$97.38M | $233.17M | $256.16M | |
| — | — | 5.94% | 4.96% | 17.02% | 17.9% | 22.36% | 16.67% | 16.46% | 13.14% | 17.35% | 17.1% | 17.46% | 15.48% | 13.75% | -6.28% | 15.25% | 16.41% | |
| — | -$26.67M | $296.11M | $425.61M | $748.43M | $730.32M | $865.46M | $650.32M | $645.62M | $536.42M | $532.62M | $447.8M | $441.23M | $411.89M | — | -$2.49M | — | — | |
| — | $107.4M | $100.22M | $83.54M | $85.08M | $54.26M | $56.97M | $66.49M | $80.27M | $103.02M | $82.55M | $54.94M | $61.32M | $65.46M | $56.91M | $69.57M | $70.32M | $79.88M | |
| — | $6.62M | $6.4M | $8.01M | $12.78M | $912K | $1.33M | $1.16M | $1.74M | $944K | $771K | $474K | $532K | $706K | $624K | $1.57M | $1.26M | $725K | |
| — | -$38.03M | $24.55M | $75.48M | $434.01M | $445.92M | $559.47M | $357.73M | $339.9M | $219.63M | $284.91M | $245.73M | $244.65M | $220.11M | $175.73M | -$165.37M | $148.7M | $130.38M | |
| — | -$39.38M | -$33.98M | $5.32M | $76.44M | $83M | $74.35M | $21.93M | -$122.08M | $23.2M | $129.65M | $8.07M | $7.84M | $28.65M | $23.55M | $16.41M | $27M | $25.23M | |
| — | -$1.01B | -$905.64M | $69.68M | $356.33M | $363.14M | $485.37M | $335.32M | $461.47M | $200.8M | $152.53M | $237.38M | $244.86M | $187.68M | $150.88M | -$190.06M | $323.33M | $201.09M | |
| — | — | -45.45% | 2.29% | 11.98% | 13.01% | 17.28% | 13.22% | 17.78% | 8.2% | 7.11% | 12.71% | 13.53% | 10.2% | 8.89% | -12.25% | 21.15% | 12.88% | |
| — | — | — | — | $445.45M | $306.58M | $435.71M | $382.42M | $458.16M | $124.81M | $326.16M | $170.62M | $134.63M | $37.64M | $172.07M | -$162.75M | — | — | |
| USD/shares | — | — | -$20.30 | $1.49 | $7.58 | $7.74 | $10.38 | $7.21 | $9.99 | $4.39 | $3.39 | $5.48 | $5.89 | $4.54 | $3.67 | -$4.65 | $7.98 | $5.04 |
| USD/shares | $2.90 – $3.20 | — | -$20.25 | $1.48 | $7.53 | $7.68 | $10.23 | $7.09 | $9.80 | $4.29 | $3.27 | $4.98 | $5.10 | $4.04 | $3.45 | -$4.65 | $7.92 | $4.99 |
| shares | — | — | 44.62M | 46.84M | 46.98M | 46.9M | 46.77M | 46.49M | 46.2M | 45.69M | 45M | 43.33M | 41.56M | 41.37M | 41.11M | 40.86M | 40.5M | 39.91M |
| shares | — | — | 44.72M | 47.09M | 47.3M | 47.31M | 47.43M | 47.29M | 47.09M | 46.8M | 46.66M | 47.65M | 48.06M | 46.47M | 43.69M | 40.86M | 40.8M | 40.28M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2025: $500M in buybacks, $957.3M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Instruments & Supplies median 1.82×
EV/EBIT
—
Medical Instruments & Supplies median 32.48×
P/E (TTM)
—
Medical Instruments & Supplies median 37.92×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Americas Segment | $1,279,197,000 | $1,156,946,000 | $1,180,709,000 | $1,926,348,000 | $1,659,309,000 | $1,465,035,000 | $1,492,274,000 | $1,351,699,000 |
| EMEA Segment | $472,411,000 | $340,255,000 | $316,972,000 | $558,373,000 | $606,807,000 | $584,859,000 | $588,043,000 | $603,813,000 |
| Asia Segment | $241,105,000 | $202,345,000 | $214,760,000 | $306,320,000 | $297,766,000 | $267,016,000 | $294,328,000 | $286,895,000 |
| Oem | — | — | — | — | $245,681,000 | $220,246,000 | $220,717,000 | $205,976,000 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| United States | $1,181,817,000 | $1,079,343,000 | $1,106,896,000 | $1,786,467,000 | $1,769,488,000 | $1,567,144,000 | $1,606,248,000 | $1,449,426,000 |
| Europe | $484,734,000 | $347,899,000 | $330,065,000 | $622,343,000 | $665,000,000 | $646,577,000 | $652,069,000 | $671,264,000 |
| Asia And Asia Pacific | $218,029,000 | $179,567,000 | $187,946,000 | $270,749,000 | $263,022,000 | $230,267,000 | $241,278,000 | $234,090,000 |
| All Other | $108,133,000 | $92,737,000 | $87,534,000 | $111,482,000 | $112,053,000 | $93,168,000 | $95,767,000 | $93,603,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Vascular Access | $917,731,000 | $903,512,000 | $841,114,000 | $683,612,000 | $700,240,000 | $657,703,000 | $600,874,000 | $575,327,000 |
| Interventional | $647,792,000 | $397,340,000 | $407,251,000 | $445,018,000 | $427,500,000 | $382,435,000 | $427,563,000 | $395,423,000 |
| Surgical | $418,155,000 | $404,869,000 | $388,325,000 | $392,917,000 | $377,756,000 | $317,200,000 | $370,074,000 | $358,707,000 |
| Other | $9,035,000 | -$6,175,000 | $75,751,000 | $285,148,000 | $336,585,000 | $367,257,000 | $347,272,000 | $366,845,000 |
| Anesthesia | — | — | — | $388,890,000 | $380,140,000 | $302,293,000 | $338,413,000 | $349,370,000 |
| Interventional Urology | — | — | — | $322,832,000 | $341,661,000 | $290,022,000 | $290,449,000 | $196,735,000 |
| Oem | — | — | — | $272,624,000 | $245,681,000 | $220,246,000 | $220,717,000 | $205,976,000 |